Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 520

1.

Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.

Korkusuz H, Knau LL, Kromen W, Bihrer V, Keese D, Piiper A, Vogl TJ.

J Magn Reson Imaging. 2012 Jun;35(6):1397-402. doi: 10.1002/jmri.23584. Epub 2012 Jan 20.

PMID:
22267126
2.

Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Saito K, Kotake F, Ito N, Ozuki T, Mikami R, Abe K, Shimazaki Y.

Magn Reson Med Sci. 2005;4(1):1-9.

3.

Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.

Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A.

Eur J Radiol. 2012 Nov;81(11):3002-9. doi: 10.1016/j.ejrad.2012.03.029. Epub 2012 Jun 29.

PMID:
22748558
4.
5.

Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.

Péporté AR, Sommer WH, Nikolaou K, Reiser MF, Zech CJ.

Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.

PMID:
23159401
6.

Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging.

Akai H, Matsuda I, Kiryu S, Tajima T, Takao H, Watanabe Y, Imamura H, Kokudo N, Akahane M, Ohtomo K.

Eur J Radiol. 2012 Nov;81(11):2973-7. doi: 10.1016/j.ejrad.2012.01.007. Epub 2012 Jan 26.

PMID:
22280873
7.

Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.

Asayama Y, Tajima T, Nishie A, Ishigami K, Kakihara D, Nakayama T, Okamoto D, Fujita N, Aishima S, Shirabe K, Honda H.

Eur J Radiol. 2011 Dec;80(3):e243-8. doi: 10.1016/j.ejrad.2010.10.032. Epub 2010 Nov 24.

PMID:
21109378
8.

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T.

AJR Am J Roentgenol. 2009 Oct;193(4):1053-60. doi: 10.2214/AJR.08.1946.

PMID:
19770329
10.

Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.

Nakamura S, Nakaura T, Kidoh M, Utsunomiya D, Doi Y, Harada K, Uemura S, Yamashita Y.

J Magn Reson Imaging. 2013 Sep;38(3):548-54. doi: 10.1002/jmri.24017. Epub 2013 Jun 6.

PMID:
23744782
11.

Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.

Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.

Eur J Radiol. 2012 Oct;81(10):2457-62. doi: 10.1016/j.ejrad.2011.10.014. Epub 2011 Dec 3.

PMID:
22138122
12.

Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA.

Zech CJ, Vos B, Nordell A, Urich M, Blomqvist L, Breuer J, Reiser MF, Weinmann HJ.

Invest Radiol. 2009 Jun;44(6):305-10.

PMID:
19462484
13.

Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.

Lee SA, Lee CH, Jung WY, Lee J, Choi JW, Kim KA, Park CM.

Magn Reson Imaging. 2011 Jan;29(1):83-90. doi: 10.1016/j.mri.2010.07.019. Epub 2010 Sep 15.

PMID:
20832227
14.

T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.

Tamada T, Ito K, Yoshida K, Sone T, Murakami K, Kanki A, Watanabe S, Higashi H, Yamashita T.

J Comput Assist Tomogr. 2010 Mar-Apr;34(2):182-6. doi: 10.1097/RCT.0b013e3181bc961b.

PMID:
20351500
15.

Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.

Toyoda H, Kumada T, Tada T, Niinomi T, Ito T, Sone Y, Kaneoka Y, Maeda A.

J Hepatol. 2013 Jun;58(6):1174-80. doi: 10.1016/j.jhep.2013.01.030. Epub 2013 Jan 29.

PMID:
23376360
16.

Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate.

Schmid-Tannwald C, Herrmann K, Oto A, Panteleon A, Reiser M, Zech C.

Acta Radiol. 2012 Nov 1;53(9):961-5. doi: 10.1258/ar.2012.120186. Epub 2012 Sep 27.

PMID:
23024179
17.

Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).

Motosugi U, Ichikawa T, Sou H, Sano K, Ichikawa S, Tominaga L, Araki T.

J Magn Reson Imaging. 2009 Oct;30(4):849-54. doi: 10.1002/jmri.21913.

PMID:
19787734
18.

Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.

Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T.

J Magn Reson Imaging. 2009 Mar;29(3):636-40. doi: 10.1002/jmri.21689.

PMID:
19243060
19.

Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma.

Saito K, Araki Y, Park J, Metoki R, Katsuyama H, Nishio R, Kakizaki D, Moriyasu F, Tokuuye K.

J Magn Reson Imaging. 2010 Jul;32(1):229-34. doi: 10.1002/jmri.22219.

PMID:
20578029
20.

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.

Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES.

Liver Transpl. 2012 Jul;18(7):850-7. doi: 10.1002/lt.23426.

Supplemental Content

Support Center